Next-generation Viral RNA/DNA in situ Hybridization Applications in Human Immunodeficiency Virus/Simian Immunodeficiency Virus Research.


Journal

Journal of visualized experiments : JoVE
ISSN: 1940-087X
Titre abrégé: J Vis Exp
Pays: United States
ID NLM: 101313252

Informations de publication

Date de publication:
17 06 2020
Historique:
entrez: 7 7 2020
pubmed: 7 7 2020
medline: 31 10 2020
Statut: epublish

Résumé

In situ hybridization is a powerful technique to identify specific RNA or DNA sequences within individual cells in tissue sections, providing important insights into physiological processes and disease pathogenesis. In situ hybridization (ISH) has been used for many years to assess the location of cells infected by viruses, but recently a next-generation ISH approach was developed with a unique probe design strategy that allows simultaneous signal amplification and background suppression to achieve single-molecule visualization while preserving tissue morphology. This next-generation ISH is based on an approach like branched PCR, but performed in situ and is more facile, sensitive, and reproducible than classical ISH methods or in situ PCR approaches in routinely detecting RNA or DNA in formalin-fixed paraffin embedded (FFPE) tissues. For the last several years our laboratory has been applying this ISH platform for the detection of human immunodeficiency (HIV) and simian immunodeficiency (SIV) viral RNA (vRNA) and/or viral DNA (vDNA) positive cells within a multitude of FFPE tissues. With this detailed technical manuscript, we would like to share our knowledge and advice with all individuals interested in using next-generation ISH in their research.

Identifiants

pubmed: 32628155
doi: 10.3791/60318
pmc: PMC8982224
mid: NIHMS1783175
doi:

Substances chimiques

DNA, Viral 0
Epitopes 0
RNA, Viral 0
Peptide Hydrolases EC 3.4.-

Types de publication

Journal Article Research Support, N.I.H., Extramural Video-Audio Media

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NCI NIH HHS
ID : HHSN261200800001E
Pays : United States
Organisme : NIH HHS
ID : P51 OD011092
Pays : United States

Références

JCI Insight. 2016 Jul 7;1(10):
pubmed: 27446990
Pathog Immun. 2016 Spring;1(1):68-106
pubmed: 27430032
Nat Rev Microbiol. 2016 Jan;14(1):55-60
pubmed: 26616417
Retrovirology. 2018 Jan 09;15(1):4
pubmed: 29316956
Curr Opin Virol. 2016 Aug;19:77-84
pubmed: 27490446
PLoS Biol. 2018 Jul 3;16(7):e2005970
pubmed: 29969450
J Mol Diagn. 2012 Jan;14(1):22-9
pubmed: 22166544
J Virol. 2018 Aug 29;92(18):
pubmed: 29997216
PLoS Pathog. 2018 Apr 19;14(4):e1006956
pubmed: 29672640
Nat Med. 2017 Nov;23(11):1271-1276
pubmed: 28967921
Immunity. 2018 May 15;48(5):872-895
pubmed: 29768175

Auteurs

Catherine Brands (C)

AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research Inc.

David Morcock (D)

AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research Inc.

Jacob Estes (J)

Vaccine and Gene Therapy Institute and Oregon National Primate Research Center (ONPRC), Oregon Health and Science University (OHSU).

Claire Deleage (C)

AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research Inc.; claire.deleage@nih.gov.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH